Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials
Maturitas · 2026
DOI: 10.1016/j.maturitas.2026.108961 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Maturitas, 2026. Verfasst von Panagiotis Anagnostis und 4 weiteren Autor:innen. Beteiligte Einrichtung: 3(rd) Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: pan.anagnostis…. Hauptthemen laut MEDLINE: Testosterone, Hypogonadism, Hormone Replacement Therapy, Fractures, Bone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Testosterone replacement therapy is the treatment of choice in men with hypogonadism. Although its beneficial effect on bone mineral density is well established, the evidence regarding its impact on fracture risk remains inconclusive. The purpose of this study was to systematically review and meta-analyze the highest-quality available evidence regarding the effect of TRT on fracture risk in hypogonadal men. STUDY DESIGN: A systematic literature search was conducted in PubMed, Scopus and Cochrane databases from inception through 30 September 2025. Only randomized controlled trials were eligible for inclusion. Outcomes were summarized as relative risk (RR), with a 95% confidence interval (CI). The I2 index was used in order to quantify heterogeneity. RESULTS: The initial search yielded 1145 results after removal of duplicates; seven papers underwent full-text assessment. Finally, two studies were included in the qualitative and quantitative analysis (n = 2711). TRT was associated with increased risk of clinical fractures compared with placebo (RR 1.55, 95% CI 1.21-1.97, p < 0.0001, I2 0%). However, no difference between groups was observed when the analysis was restricted to major osteoporotic fractures (hip, spine, wrist, and arm) (RR 0.62, 95% CI 0.12-3.35, p = 0.58, I2 63%). This was also the case for vertebral (RR 0.87, 95% CI 0.29-2.58, p = 0.80, I2 9%) and hip fractures (RR 1.02, 95% CI 0.33-3.09, p = 0.98, I2 0%), when analyzed separately. CONCLUSION: TRT is associated with an increased incidence of predominantly non-major fractures, while the risk of major osteoporotic fractures, including hip and vertebral fractures, was not increased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 3(rd) Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece. Electronic address: pan.anagnostis@gmail.com.
- Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece.
- 3(rd) Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Centre of Expertise in Rare Endocrine Diseases, C.E.R.E.D - Disorders of Calcium and Phosphate Metabolism, Endocrinology Unit, 1st Department of Propaedeutic Internal Medicine, LAIKO General Hospital of Athens, National…
- Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, Athens, Greece.
Zitieren
APA
Anagnostis, P., Divaris, E., Zidrou, M., Kassi, E., & Tournis, S. (2026). Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials. Maturitas. https://doi.org/10.1016/j.maturitas.2026.108961
Vancouver
Anagnostis P, Divaris E, Zidrou M, Kassi E, Tournis S. Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials. Maturitas. 2026. doi:10.1016/j.maturitas.2026.108961
BibTeX
@article{Anagnostis2026,
author = {Anagnostis, Panagiotis and Divaris, Efstathios and Zidrou, Maria and Kassi, Evanthia and Tournis, Symeon},
title = {Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials},
journal = {Maturitas},
year = {2026},
doi = {10.1016/j.maturitas.2026.108961}
}
EUVIMED